16-fluoroestradiol has been researched along with Endometrial Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okazawa, H; Tsujikawa, T; Tsuyoshi, H; Yamada, S; Yoshida, Y | 1 |
| Fujibayashi, Y; Kiyono, Y; Kobayashi, M; Kotsuji, F; Kudo, T; Kurokawa, T; Okazawa, H; Tsuchida, T; Tsujikawa, T; Yoshida, Y | 1 |
| Fujibayashi, Y; Kiyono, Y; Kotsuji, F; Kudo, T; Kurokawa, T; Okazawa, H; Tsujikawa, T; Yoshida, Y | 1 |
| Fujibayashi, Y; Kotsuji, F; Kurokawa, T; Okazawa, H; Sawamura, Y; Shinagawa, A; Yoshida, Y | 1 |
2 trial(s) available for 16-fluoroestradiol and Endometrial Neoplasms
| Article | Year |
|---|---|
Functional images reflect aggressiveness of endometrial carcinoma: estrogen receptor expression combined with 18F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Estradiol; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Receptors, Estrogen; ROC Curve | 2009 |
Functional oestrogen receptor α imaging in endometrial carcinoma using 16α-[¹⁸F]fluoro-17β-oestradiol PET.
Topics: Biological Transport; Endometrial Neoplasms; Estradiol; Estrogen Receptor alpha; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Middle Aged; Positron-Emission Tomography | 2011 |
2 other study(ies) available for 16-fluoroestradiol and Endometrial Neoplasms
| Article | Year |
|---|---|
Predictive Value of 16α-[18F]-Fluoro-17β-Estradiol PET as a Biomarker of Progestin Therapy Resistance in Patients With Atypical Endometrial Hyperplasia and Low-Grade Endometrial Cancer.
Topics: Adult; Endometrial Hyperplasia; Endometrial Neoplasms; Estradiol; Female; Humans; Positron-Emission Tomography; Progestins; Radiopharmaceuticals | 2019 |
The positron emission tomography with F18 17beta-estradiol has the potential to benefit diagnosis and treatment of endometrial cancer.
Topics: Adenocarcinoma; Adult; Endometrial Neoplasms; Estradiol; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |